FDA Announces Recall of Popular Antidepressant Over Possible Carcinogen Risk


The recalled meds may have unsafe levels of a carcinogen.Credit: Grace Cary / Getty Images / Health.com
The recalled meds may have unsafe levels of a carcinogen.
Credit: Grace Cary / Getty Images / Health.com
  • Almost 375,000 bottles of the antidepressant duloxetine have been recalled.
  • The drugs may contain unsafe levels of nitrosamines, chemicals that can raise the risk of cancer over time.
  • The recall was given the second-highest risk level, but talk to a healthcare provider before stopping the medication.

Nearly 375,000 bottles of the antidepressant duloxetine have been recalled, according to the Food and Drug Administration. Breckenridge Pharmaceutical, Inc. recalled the medication on June 4 due to higher-than-acceptable levels of nitrosamines, chemical compounds that may increase the risk of cancer if people are exposed to them above acceptable levels for long periods of time.

On June 8, the FDA gave the recall the second-highest risk level, Class II, indicating the potential for temporary or reversible health consequences from the affected drugs.

Which Antidepressants Were Recalled?

The manufacturer recalled two doses of prescription-only duloxetine, which can be identified with the following information:

Duloxetine Delayed-Release Capsules, USP, 30 mg

  • Size: 1,000 capsules
  • Expiration date: April 2027, with lot code: 241180C
  • Affected quantity: 14,729 bottles

Duloxetine Delayed-Release Capsules, USP, 60 mg

  • Sizes: 90 capsules and 1,000 capsules
  • Expiration date: November 2026, with lot code: 232311
  • Expiration date: January 2027, with lot code: 240316
  • Expiration date: February 2027, with lot codes: 240317, 240318, 240315C, 240373C, 240370C, 240375C, and 240413C
  • Expiration date: April 2027, with lot codes: 240978C and 241052C
  • Expiration date: May 2027, with lot code: 241074C
  • Affected quantity: 359,676 bottles

What You Should Do

If you have the recalled duloxetine, contact your doctor or pharmacist for a replacement and ask about the best course of action. Class II recalls pose the risk of adverse health consequences, but stopping a medication could be riskier.

“While recall notifications can be frightening, it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine,” Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices, previously told Health. “Some medicines … should not be stopped suddenly.”



Source link

Leave a Reply

Subscribe to Our Newsletter

Get our latest articles delivered straight to your inbox. No spam, we promise.

Recent Reviews


Barbra Streisand
Getty

Barbra Streisand is set to be honored at the 2026 Cannes Film Festival, but she will no longer be attending the ceremony.

The 84-year-old icon will sadly not be there to accept her honorary Palme d’Or at the closing ceremony of the film festival due to a knee injury.

“On the advice of my doctors, as I continue recovering from a knee injury, I am sadly unable to attend the Festival de Cannes this year,” she shared in a statement, via Variety.

“But I am deeply honored to receive the honorary Palme d’Or and had so been looking forward to celebrating the remarkable films of the 79th edition.”

“I was also very much looking forward to spending time with colleagues whom I so admire — and, of course, returning to France, a place I have always loved. While I regret that I can’t be there in person, I want to extend my warmest congratulations to all of the filmmakers from around the world whose extraordinary talent and creative vision are being celebrated this year,” the statement continues.

“My heartfelt thanks to the Festival, and to everyone who continues to support and champion the art of cinema.”

The tribute will still happen on May 23.

Iris Knobloch, Thierry Frémaux and the entire festival team send Barbra Streisand their warmest wishes for a prompt recovery,” the festival said in a press release.

Barbra will be the third person to get an honorary Palme d’Or in 2026, including Peter Jackson and John Travolta.

If you missed it, Jane Fonda recently questioned why Barbra got to do Robert Redford‘s In Memoriam tribute at the 2026 Oscars, when she worked with him more often.

The post Why Barbra Streisand Is Skipping Her Cannes Film Festival 2026 Honorary Ceremony appeared first on Just Jared – Celebrity News and Gossip | Entertainment.



Source link